Today's Fresh Blogs...

• Measles Cases on the Rise

  Published: February 23, 2008, 6:00 pm

  Tags: California, Health, Legal Issues, Vaccines, Andrew Wakefield, Asd, Asperger, Autism, Baltimore, Herd Immunity, Measles, Mercury, Mmr, Parenting, Pdd Nos, San Diego, Shots, Wyeth

  a case involving drug maker Wyeth and the parents of Jamarr Blackwell: “It is generally accepted in the relevant scientific community that thimerosal in vaccines does not cause or contribute to neurodevelopmental disorders such as autism.” “It generally accepted in the relevant scientific community that autism is genetic in

  Comments (0)   Blog link Rating: 0

• Wyeth reps no like Pristiq

  Published: April 21, 2008, 3:44 am

  Tags: Medicine Medication, Weblogs, Carlat, Carlat Psychiatry Blog, Desvenlafaxine, Drug Reps, Drugs, Effexor Xr, Marketing, Medication, Meds, Passion, People, Performance, Pristiq, Psych Drugs, Psychiatry, Slogans, Venlafaxine, Wyeth

  upon this post about Wyeth drug reps trashing Pristiq. Wow. Carlat pulled an excerpt of a Wyeth rep mocking Pristiq's new marketing slogan: "People, Passion, Performance... Pristiq!""PEOPLE - 1/2 of you will be gone in less than 27 days PASSION - There is no passion now, but for those that remain with Wyeth, we will bribe the passion

  Comments (0)   Blog link Rating: 0

• Closing Bell: Scary undertones and major news mask a mixed day

  Published: April 25, 2008, 12:45 pm

  Tags: Bidu, Nelson Peltz, Nelsonpeltz, Pgnx, Relistor, Wyeth

  the company and its partner Wyeth received federal approval late Thursday for Relistor, a medication used to treat constipation. Shares were up 26% at $13.44 in the final moments of trading.Wendy's International Inc. (NYSE: WEN) saw shares recover by 7% to $28.26 in the final moments of trading after Wall Street gave Nelson Peltz the thumbs

  Comments (0)   Blog link Rating: 0

• Poor Wyeth New drug delayed in FDA approval

  Published: May 23, 2008, 2:12 pm

  Tags: Medicine Medication, News, Bazedoxifene, Blood Clots, Desvenlafaxine, Drug, Effexor, Fda Approval, Forbes Com, Medication, Meds, Myocardial Infarctions, Osteoporosis, Postmenopausal, Postmenopause, Pristiq, Strokes, Venlafaxine, Wyeth, Wyeth Pharmaceuticals

  Forbes.com: Wyeth Pharmaceuticals just can't seem to catch a break. The company is not only increasingly worried that it will lose a large chunk of its revenues to generic competition, it also faces the ongoing threat that its pipeline is starting to go dry. A further delay in the approval of its postmenopausal osteoporosis drug has become

  Comments (0)   Blog link Rating: 0

• Democrats' Convention Pool: Is It All Wet?

  Published: May 27, 2008, 12:00 am

  Tags: Democrats, Convention, Pool, All, Wet, Democratic National Committee, Natalie Wyeth, Yobachi Boswell, Fannie Lou Hamer, Francis L Holland, Hollywood, Moulitsas Zuniga, Nashville, Silver Spring, Knoxviews Com, Kos Media Llc, Netherlands, Theybf Com, Georgia, Mississipp

  Forget the row over RFK, the latest superdelegate tally or Saturday's sure-to-be contentious meeting of the Rules and Bylaws Committee.

  Comments (0)   Blog link Rating: 0

• Genocea Teams With Nonprofit PATH on Vaccine for Children in Developing World

  Published: July 9, 2008, 6:24 am

  Tags: Boston, Boston Blog Main, National Blog Main, Seattle Blog Main, Biotech, Vaccines, Global Health, Gates Foundation, Centers For Disease Control And Prevention, Wyeth, Merck, Path, Genocea, Prevnar, Robert Paull

  a vaccine made by drug giant Wyeth, and do it at a fraction of the price. Prevnar has become a runaway success in the U.S. and other wealthy countries, generating $2.4 billion in worldwide sales in 2007. It works by building up infants’ immune defenses against pneumococcal bacteria, which can cause deadly pneumonia and meningitis

  Comments (0)   Blog link Rating: 0

• Allen Institute Releases First Data for Spinal Cord Researchers, Unveils New Financing Model

  Published: July 17, 2008, 12:01 am

  Tags: National Blog Main, Seattle, Seattle Blog Main, Biotech, Spinal Cord, Brain Science, Life Sciences, Paul Allen, Microsoft, Allan Jones, Senator Patty Murray, Paralyzed Veterans Of America, Als Association, Wyeth Research, Pemco Insurance, National Multiple Sclerosis Soc

  a reality—including Wyeth Research, Pemco Insurance, and the National Multiple Sclerosis Society–have agreed to kick in about $600,000 of the estimated $2.3 million cost of the project, Jones says. It’s the first time the Allen Institute has brought such a group together to fund a project, and a model that the Institute hopes

  Comments (0)   Blog link Rating: 0

• Caliper Bets Future on Tools That Light Up Genes Before Researchers' Eyes

  Published: July 28, 2008, 9:30 am

  Tags: Boston, Boston Blog Main, National Blog Main, Biotech, Cancer, Devices, Life Sciences, Caliper Life Sciences, Kevin Hrusovsky, Sugen, Pfizer, Sutent, Fda, Xenogen, Novartis, Merck, Amgen, Sanofi Aventis, Vertex Pharmaceuticals, Wyeth, Johnson Amp Amp Johnson, Russell 3000

  (NASDAQ: VRTX), Wyeth, and Johnson & Johnson use it too. Caliper’s stock has been sliding much of the year, but has rebounded 53 percent since June 30, when it was added to the Russell 3000 Index. That meant Caliper shares were suddenly getting bought by mutual funds and index funds, Hrusovsky said. So where is this

  Comments (0)   Blog link Rating: 0

• Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge

  Published: August 14, 2008, 12:01 am

  Tags: Boston, Boston Blog Main, National Blog Main, Biotech, Inflammation, Taligen, Abbie Celniker, Genentech, Wyeth Biopharma, Millennium Pharmaceuticals, Novartis Biologics, Amgen, Enbrel, Biogen Idec, Elan, Tysabri, Multiple Sclerosis, Crohn S Disease, Asthma, Macular Degenera

  R&D jobs at Genentech, Wyeth Biopharma, Millennium Pharmaceuticals, and most recently as global head of Novartis Biologics in Cambridge, MA. Now, at 49, she has taken a detour to become CEO of a growing startup company in Cambridge called Taligen Therapeutics. At big companies, the higher Celniker climbed, the further she got from her roots

  Comments (0)   Blog link Rating: 0